Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The gap between biohacker enthusiasm and clinical evidence remains vast, but specific compounds merit continued attention for prevention-focused research
Stable Gastric Pentadecapeptide BPC 157 Current Status in Wound Healing
Neuropsychobiology , 9 4, 197-206
The 2017 foundational studies confirmed that 5amino1mq reduces NAD consumption via NNMT inhibition, improves glucose clearance, and decreases fat accumulation.In subsequent years, the scope expanded: a 2021 study in obese mice validated its antiobesity effects, and 2024 research revealed improvements in muscle function in aged mice.To date, the compound remains in the preclinical research stage, with no largescale human clinical trials or FDA approval for human use
Phytomedicine: international journal of phytotherapy and phytopharmacology
"I'm concerned about the impact some may have on the kidneys
US$ 27.42
US$ 26.49
US$ 20.03